Literature DB >> 33540122

Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health.

R K Kumar1, L M Kaiser2, C E Rockwell2, S W Watts2.   

Abstract

Perivascular adipose tissue (PVAT) is protective and reduces contraction of blood vessels in health. PVAT is composed of adipocytes, multiple types of immune cells and stromal cells. Interleukin (IL)-10, an anti-inflammatory cytokine usually produced by T cells, B cells and macrophages, was identified as one of the highly expressed (mRNA) cytokines in the mesenteric PVAT of healthy rats. One report suggested that exogenous IL-10 causes relaxation of mouse mesenteric arteries, also suggesting that IL-10 maybe a potential anti-contractile factor. Hence, we hypothesized that PVAT-derived IL-10 causes vasorelaxation and/or reduces vasoconstriction, thus contributing to the anti-contractile nature of PVAT in health. Mesenteric arteries from rats and mice expressed the receptor for IL-10 (in tunica intima and media) as determined by immunohistochemistry. Mesenteric resistance arteries for rats and superior mesenteric artery for mice were used for isometric contractility studies. Increasing concentrations [0.4-100 ng/mL] of recombinant rat/mouse (rr/mr) IL-10 or vehicle was directly added to half-maximally constricted (phenylephrine, PE) vessels (without PVAT, with endothelium). IL-10 did not cause a direct vasorelaxation. Further, the ability of rrIL-10 to cause a rightward or downward shift of a vasoconstriction-response curve was tested in the rat. The vessels were incubated with rrIL-10 [100 ng/mL or 10 ng/mL] or vehicle for 1.5 h in the tissue bath followed by a cumulative PE [10-8-10-4 M] or U46619 [10-10-10-5 M] response curve. The maximal contractions and EC50 values were similar in IL-10 incubated vessels vs vehicle. Thus, acute exposure of exogenous IL-10 did not reduce local vasoconstriction. To further test if endogenous IL-10 from PVAT was anti-contractile, superior mesenteric arteries from IL-10 WT and KO mice, with and without PVAT, were subjected to increasing concentrations of PE. The anti-contractile nature of PVAT was preserved with both short-term and prolonged depletion (using younger and older mice, respectively) of endogenous IL-10 in males and females. Contrary to our hypothesis, PVAT-derived IL-10 neither caused vasorelaxation nor reduced local vasoconstriction directly/indirectly. Therefore, IL-10 does not contribute to the anti-contractile nature of PVAT in healthy rodents.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-contractile; IL-10; Perivascular adipose tissue; Vascular tone; Vasorelaxation

Mesh:

Substances:

Year:  2021        PMID: 33540122      PMCID: PMC8174099          DOI: 10.1016/j.vph.2021.106838

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.738


  27 in total

1.  Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries.

Authors:  Stefan Verlohren; Galyna Dubrovska; Suk-Ying Tsang; Kirill Essin; Friedrich C Luft; Yu Huang; Maik Gollasch
Journal:  Hypertension       Date:  2004-08-09       Impact factor: 10.190

2.  Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.

Authors:  Modar Kassan; Maria Galan; Megan Partyka; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

3.  Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide.

Authors:  Carol A Gunnett; Donald D Heistad; Frank M Faraci
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

4.  Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue.

Authors:  Agostino Virdis; Emiliano Duranti; Chiara Rossi; Umberto Dell'Agnello; Eleonora Santini; Marco Anselmino; Massimo Chiarugi; Stefano Taddei; Anna Solini
Journal:  Eur Heart J       Date:  2014-02-26       Impact factor: 29.983

5.  Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age.

Authors:  Gautam Sikka; Karen L Miller; Jochen Steppan; Deepesh Pandey; Sung M Jung; Charles D Fraser; Carla Ellis; Daniel Ross; Koenraad Vandegaer; Djahida Bedja; Kathleen Gabrielson; Jeremy D Walston; Dan E Berkowitz; Lili A Barouch
Journal:  Exp Gerontol       Date:  2012-11-13       Impact factor: 4.032

6.  Effects of inflammatory cytokines on vascular tone.

Authors:  F Ohkawa; U Ikeda; T Kanbe; K Kawasaki; K Shimada
Journal:  Cardiovasc Res       Date:  1995-11       Impact factor: 10.787

7.  Eosinophils are key regulators of perivascular adipose tissue and vascular functionality.

Authors:  Sarah B Withers; Ruth Forman; Selene Meza-Perez; Daniel Sorobetea; Kasia Sitnik; Thomas Hopwood; Catherine B Lawrence; William W Agace; Kathryn J Else; Anthony M Heagerty; Marcus Svensson-Frej; Sheena M Cruickshank
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

8.  T Cells Are Dominant Population in Human Abdominal Aortic Aneurysms and Their Infiltration in the Perivascular Tissue Correlates With Disease Severity.

Authors:  Agnieszka Sagan; Tomasz P Mikolajczyk; Wojciech Mrowiecki; Neil MacRitchie; Kevin Daly; Alan Meldrum; Serena Migliarino; Christian Delles; Karol Urbanski; Grzegorz Filip; Boguslaw Kapelak; Pasquale Maffia; Rhian Touyz; Tomasz J Guzik
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

9.  Cytokine levels in the serum of healthy subjects.

Authors:  Giulio Kleiner; Annalisa Marcuzzi; Valentina Zanin; Lorenzo Monasta; Giorgio Zauli
Journal:  Mediators Inflamm       Date:  2013-03-07       Impact factor: 4.711

10.  Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway.

Authors:  Fernanda R C Giachini; Saiprasad M Zemse; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Glaucia E Callera; Adviye Ergul; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-12       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.